MeSH Browser

MeSH Supplementary: aclacinomycins
Unique ID: C011157
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C011157
Entry Term(s): MA 144 N1; MA 144 S1; aclacinomycin; aclacinomycin B; aclacinomycin Hydrochloride; aclacinomycin M; aclacinomycin N; aclacinomycin S; aclacinomycin T; aclacinomycin X; aclacinomycin Y; siwenmycin
Pharm Action: Adjuvants, Immunologic
Antibiotics, Antineoplastic
Registry Numbers: 0; 66676-88-8; 64474-88-0; 64431-69-2; 108147-58-6; P8EJD9HI5K; 60504-57-6; 64431-68-1; 67298-12-8; 74564-62-8
Related Numbers: 108147-58-6; 57596-79-9; 60504-57-6; 64431-68-1; 64431-69-2; 64474-88-0; 66676-88-8; 67298-12-8; 74564-62-8; P8EJD9HI5K
Previous Indexing: ANTHRAQUINONES (76-78); GLYCOSIDES (76-78); NAPHTHACENES (76-88)
Heading Mapped to: Aclarubicin / analogs & derivatives
Frequency: 163
Source: Antibiot Chemother 23:76;1978; Biochem Biophys Res Commun 82(1):188;1978; Biochemistry 1979;18(18):4024; Cancer Res 38:1782;1978; Cancer Treat Rep 63(5):875;1979; Cancer Treat Rep 63(5):931;1979; Folia Microbiol 23:152;1978; Gann 68(5):685;1977; J Antibiot 1979;32(5):472; J Antibiotics 28(10):830;1975; J Antibiotics 31(9):919;1978; J Antibiot (Tokyo) 32(1):48;1979; Jpn J Antibiot 30 suppl:S-70;1977; Lancet 2(8137):301;1979; Recent Results Canc Res 63:241;1978
Date of Entry: 1976/01/01
Revision Date: 2015/08/17

aclacinomycins MeSH Supplementary Concept Data 2024